Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
주식 순위 #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
주가
$1.05
시가총액
$25.12M
변동 (1일)
0.00%
변동 (1년)
-86.83%
국가
US
거래 Actuate Therapeutics Inc (ACTU)

카테고리

Actuate Therapeutics Inc (ACTU)의 주가 이력
최고 종가: $1.04 (2026-08-01 기준)

최저 종가: $8.39 (2024-08-01 기준)
Actuate Therapeutics Inc의 주가 이력 (2024 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -36.39%
2025 -14.02%
2024 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH